Trigyn: Bad debts cause bad results - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Trigyn: Bad debts cause bad results

Feb 6, 2001

Trigyn’s 3QFY01 performance is quite dismal compared to 2QFY01. This quarter (3QFY01) it has not been able to show any growth, neither in revenues nor in operating margins. The company has written off Rs 70 m due to bad receivables. On account of these bad debts the net profit has taken a severe hit and the company declared losses. If we do a sequential (quarter-on-quarter, QoQ) comparison revenues have come down by about 4% and the net profits have dipped by 166%. Excluding the write off the company’s net profits would have gone down by 42%. On a YoY basis the company’s revenue has grown by 36.2%. The only figure that has shown growth this quarter is total expenditure that grew by 2.7% QoQ. This has caused the operating margins to dip from 21.7% in 2QFY01 to 16.1% in 3QFY01. Of the bad debts, according to the company, Rs 50 m are due to a dot com that could not pay its bills as it did not get second round of funding. The remaining amount of Rs 20 m is due to bills that have not been paid by a customer. This particular customer according to the company has a record to stretching payments and has had receivables up to 180 days.

(Rs m) 2QFY01 3QFY01 Change
Sales 238 229 -3.8%
Other Income 40 12 -70.3%
Expenditure 187 192 2.7%
Operating Profit (EBDIT) 52 37 -29.0%
Operating Profit Margin (%) 21.7% 16.1%  
Interest 2 2 -19.8%
Depreciation 7 6 -8.3%
Profit before Tax 84 41 -51.4%
Tax 27 8 -70.4%
Extra-ordinary item 0 70  
Profit after Tax/(Loss) 57 -38 -166%
Net profit margin (%) 23.7% -16.4%  
No. of Shares (eoy) (m) 14.8 14.8  
Diluted Earnings per share* 15.2 -  
P/E (at current price) 28 -  
*(annualised)      

The company plans to control its expenditure and market aggressively to improve its performance. According to the company, the drop in operating margins is due to high SGA (selling and general administration) expenditure. The company plans to counter this by reducing the salaries of top management (who will be given stock options in lieu of salary) and introducing stringent performance standards for marketing group.

Trigyn hived off e-vector, its WAP enabling software into a separate company. The company is expected to gross US $ 6.4 m in its first year of operation. Also, Trigyn is to introduce two new products Apollo (a billing software) and e-CRM software.

On a consolidated basis the company’s revenues have jumped 61% in the 3QFY01. The operating margins for the quarter are 12%. However, this too is not without blips. Here too, Trigyn had to write off Rs 160.9 m on a consolidated basis. End result, the company has suffered a loss.

Trigyn needs to put a very smart risk management system in place. Also, it has to improve its performance. The company has targeted operating margins of 30% by 2QFY02. The main push for growth will come from e-vector, which is a subsidiary. Therefore, the operating margins on a consolidated basis are quite likely to touch the levels indicated by the company.

The stock is trading at a P/E multiple of 84 times its 9 months FY01 annualised earnings. This is quite high compared to its peers in the industry.

Equitymaster requests your view! Post a comment on "Trigyn: Bad debts cause bad results". Click here!

  

More Views on News

If You had Invested Rs 1 Lakh in TCS in 2011, this is how Much You Would have Today (Views On News)

Nov 30, 2021

Did TCS perform better than the market and its peers?

India's Top 4 IT Companies are Struggling. Here's Why... (Views On News)

Oct 22, 2021

As attrition rates are unbelievably high, top Indian IT companies are going for big-ticket raises, and much more hiring this year.

Infosys had an Exceptional Quarter Buoyed by Huge Deal Wins. Revenue Guidance Boosts Stock (Views On News)

Oct 14, 2021

Infosys raised its forecast for annual revenue growth to 16.5-17.5% from the earlier 14-16%, predicted in July 2021.

Info Edge: The Anatomy of an Indian Internet Behemoth (Views On News)

Oct 2, 2021

Info Edge is very popular in the Indian startup ecosystem due to its active participation in funding events.

This Indian Company is Tapping into the Huge Autonomous Driving Opportunity (Views On News)

Sep 14, 2021

Despite many challenges, Indian companies and startups have not shied away from entering this space.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRIGYN TECHNOLOGIES SHARE PRICE


Dec 6, 2021 03:36 PM

TRACK TRIGYN TECHNOLOGIES

  • Track your investment in TRIGYN TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TRIGYN TECHNOLOGIES

TRIGYN TECHNOLOGIES - NUCLEUS SOFTWARE COMPARISON

COMPARE TRIGYN TECHNOLOGIES WITH

MARKET STATS